Stable formulations of linaclotide
US10702576B2 · kind B2 · utility
0Cited by
42References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 17, 2019 |
| Grant date | Jul 7, 2020 |
| Priority date | — |
| Expiry date | Jan 17, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.